View on Pubmed.gov 37539732 | View on doi.org 10.1002/cnr2.18...
Exploring the human microbiome - A step forward for precision medicine in breast cancer.
- Centre for Translational Cancer Research: A Joint Initiative of Indian Institute of Science Education and Research (IISER) Pune and Prashanti Cancer Care Mission (PCCM), Pune, India.
- Life Sciences R&D, TCS Research, Tata Consultancy Services Limited, Pune, India.
- TCS Genomics Lab, Tata Consultancy Services Limited, New Delhi, India.
- Prashanti Cancer Care Mission, Pune, India and Orchids Breast Health Centre, a PCCM initiative, Pune, India.
Abstract
BACKGROUND
The second most frequent cancer in the world and the most common malignancy in women is breast cancer. Breast cancer is a significant health concern in India with a high mortality-to-incidence ratio and presentation at a younger age.
RECENT FINDINGS
Recent studies have identified gut microbiota as a significant factor that can have an influence on the development, treatment, and prognosis of breast cancer. This review article aims to describe the influence of microbial dysbiosis on breast cancer occurrence and the possible interactions between oncobiome and specific breast cancer molecular subtypes. The review further also discusses the role of epigenetics and diet/nutrition in the regulation of the gut and breast microbiome and its association with breast cancer prevention, therapy, and recurrence. Additionally, the recent technological advances in microbiome research, including next-generation sequencing (NGS) technologies, genome sequencing, single-cell sequencing, and microbial metabolomics along with recent advances in artificial intelligence (AI) have also been reviewed. This is an attempt to present a comprehensive status of the microbiome as a key cancer biomarker.
CONCLUSION
We believe that correlating microbiome and carcinogenesis is important as it can provide insights into the mechanisms by which microbial dysbiosis can influence cancer development and progression, leading to the potential use of the microbiome as a tool for prognostication and personalized therapy.
References
Perm J. 2020;24:
Genome Med. 2021 Apr 16;13(1):60
Acta Biomater. 2021 Sep 15;132:473-488
Nat Microbiol. 2022 Jun;7(6):780-795
Cited by 13 citations (total)
Journal Article Review Research Support, Non-U.S. Gov't
Exploring the human microbiome - A step forward for precision medicine in breast cancer.
Electronic publication date November 15, 2023
Asmita Jotshi [...] Rupa Mishra et al.
BACKGROUND
The second most frequent cancer in the world and the most common malignancy in women is breast cancer. Breast cancer...
Journal Article Review
The Effect of Microbiome-Derived Metabolites in Inflammation-Related Cancer Prevention and Treatment.
Electronic publication date May 28, 2025
Alice N Mafe [...] Dietrich Büsselberg et al.
Chronic inflammation plays a crucial role in cancer development, yet the mechanisms linking the microbiome to inflammation-related carcinogenesis remain unclear....
Conflict of interest statement
MeSH
- •
- •
- •
- •
- •
- •
- •
Specialties
- •
- •
- •
- •
Copyright
© 2023 The Authors. Cancer Reports published by Wiley Periodicals LLC.